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1. Introduction 
The proteinases of the gastric juice are secreted as 
inactive precursors which are irreversibly converted 
into the usually known enzymes by limited proteolysis 
releasing from 42-45 amino acid residues [l-4]. To 
initiate this process no other activating agents than 
hydrogen ions are required. It is generally accepted 
today that the initial stage in the activation process is 
a conformational change of the zymogen molecule from 
inactive to active conformation [5-81, but for the sub- 
sequent pathway of the activation, different views have 
been reported. 
Bustin and Conway-Jacobs [9] coupled porcine 
pepsinogen A to Sepharose in such concentrations that 
interactions between individual pepsinogen molecules 
would be very limited. After exposure to acid, active 
enzyme and new N-terminal isoleucine were observed. 
Al-Janabi et al. [lo] showed by activation of porcine 
pepsinogen A in solution at pH 2 that the conversion 
of alkali-stable pepsinogen to an alkali-labile product 
follows a first order reaction. Sanny et al. [ 111 found 
that the initial cleavage product formed during acti- 
vation at pH 2 had the N-terminal sequence Ile-Gly-. 
They concluded that during activation of porcine pep- 
sinogen at pH 2 the peptide’bond Leu44-Ile4s is the 
first to be cleaved. This is in contrast to experiments 
of Dykes and Kay [12]. At pH 2.5 they activated 
porcine pepsinogen in present- of the inhibitor 
pepstatin [ 131 and from the ,mino acid composition 
of the peptides produced during the reaction they 
inferred that peptide bond Leur6-he,, was cleaved 
first. For the intermediate (which was inhibited in 
their experiments) they suggested the name 
‘pseudopepsin’. 
The experiments reported in this paper confirm 
that at pH 2 the predominant initial cleavage occurs at 
peptide bond 16-l 7. This cleavage is the results of an 
intramolecular reaction and we show that the pseudo- 
pepsin has proteolytic activity and is alkali-labile. 
2. Experimental 
Porcine pepsinogen A was from Worthington (lot No. 
PG 1 GB). Amino acid analyses were performed with 
a Durrum D-500 analyzer. 
2.1. Milk clotting assay 
Skim-milk powder (12 g) was reconstituted with 
50 ml water. After addition of 50 ml 0.4 M sodium 
acetate, pH 4.9, the final pH was 5.3. The assay was 
carried out at 30°C in bifurcated tubes as described by 
Foltmann [5]. Clotting times from 1-15 min were 
found to be inversely proportional to enzyme concen- 
tration. The activity which gave a clotting time of 1 min 
was used as milk-clotting unit (U). The specific activity 
was calculated as U/ml Azso. 
To determine the maximum activity of the prepara- 
tion, activation in solution was carried out for 20 min 
at 25’C with 2.3 mg pepsinogen/ml in 0.015 M HCl 
containing 0.015 M KCl. The specific activity of this 
mixture was 22 U/ml Azse. The activity of the activa- 
tion mixtures are expressed as percent of this maximum 
activity. 
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2.2. Activation of pepsinogen in solution 2.3. Activation ofSepharose-bound pepsinogen 
To investigate the appearance of milk-clotting 
activity, activation experiments were carried out with 
low concentrations of pepsinogen (0.08-0.32 mg/ml) 
in salt-free solutions at 0°C (ice-bath). For each deter- 
mination 100 fi pepsinogen solution was rapidly 
mixed with 100 ~1 0.02 M HCl (magnetic stirring), the 
resulting mixture was found to have pH 2.1, indepen- 
dent of the pepsinogen concentration used. After the 
required period of activation, the reaction was stopped 
by rapid addition 900 ~10.1 M sodium citrate, pH 
5.3. Aliquots of such solutions were used for the milk 
clotting assay. To check that no further activation took 
place at pH 5.3 the following test was made: a sample 
of pepsinogen was activated for 40 s as described above; 
the activity of this solution was measured several times 
durihg a working day period, and no change in activity 
was observed. 
Sepharose 6B@ from Pharmacia was CNBr-activated 
according to Marsh et al. [ 161 (CNBr, purum, from 
Fluka was used). Porcine pepsinogen was coupled to 
the matrix as described by Bustin and Conway-Jacobs 
[9]. After acid hydrolysis the concentration of pepsin- 
ogen bound to Sepharose was determined by amino 
acid analysis. 
For alkaline inactivation of enzymes formed during 
the activation of pepsinogen, 200 ~.cl of an activation 
mixture was mixed with 200 ~10.5 M Tris, pH 8.5. 
The solution was left for 20 min at 25°C and the milk 
clotting activity was determined after adjustment to 
pH 5.3 with 700 1.t1 sodium citrate 0.1 M, pH 4.25. 
Sepharose-pepsinogen (0.3-0.5 g wet wt) was 
packed in columns 6 mm diameter. Activation was 
initiated by addition of 0.5 ml 0.1 M HCl followed by 
1 .l ml 0.01 M HCl and the flow was stopped. The 
exposure to acid varied from 30 min-20 h, then the 
column was washed with 1 ml 0.5 M sodium hydrogen- 
carbonate, pH 9.8, containing 1.3% SDS (the coupling 
buffer used for sequencing). With 300 ~1 of this 
buffer the content of the column was transferred to 
tubes used for Edman degradation. Unactivated mate- 
rial was prepared for sequencing in the same way, but 
without addition of acid. 
3. Results and discussion 
To determine formation of protein with new 
N-terminal amino acid sequences during the activation 
of pepsinogen, reaction mixtures containing 0.8 mg 
pepsinogen (20 nmol) in 2.5- 10 ml 0.01 M HCl were 
precipitated by rapid addition of 50% trichloroacetic 
acid to a final concentration of 20%. The mixtures 
were left for at least 30 min at 0°C the precipitates 
were collected by centrifugation, washed with 3 X 1 
ml ice cold acetone and dried. The N-terminal amino 
acid sequences were then determined as described 
by Klemm et al. [ 141. In this procedure the liberated 
residues are indentified by quantitative amino acid 
analysis after conversion with hydriodic acid [ 151. 
The conversion of pepsinogen into active enzymes 
was observed through the increase of milk-clotting 
activity; this assay was carried out at pH 5.3. We 
cheked that no further activation occurred at pH 5.3, 
and so we were able to assay the active enzymes in 
presence of zymogen. Furthermore the conversion of 
pepsinogen was studied by determinations of N-term- 
inal amino acid sequences of protein in solutions and 
of Sepharose-bound material. 
The results of the sequencing experiments are shown 
in fig-l. In unactivated preparations of Sepharose-bound 
pepsinogen only the N-terminal sequence of the 
zymogen was observed. After exposure to acid, the 
pepsinogen 
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Fig.1. N-Terminal sequence of porcine pepsinogen A [ 18-201. (2) Indicates the sequence found in activated Sepharose-bound 
pepsinogen. (7) Indicates the sequences observed after activation of pepsinogen in solution. 
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N-terminal propart of the zymogen remains coupled 
‘to the matrix, but in addition to this, the only N- 
terminal sequence was Ile-Lys-Asp-, corresponding 
to residues 17-19, the N-terminal sequence of 
pseudopepsin. There was no difference whether the 
pepsinogen had been exposed to acid for 30 min or for 
20 h, and the same sequence was found in preparations 
containing from 0.9-l .8 mg pepsinogen/wet wt Sepha- 
rose. 
Figure 1 further shows the N-terminal sequences 
determined after activation in solution. Only residues 
that could be assigned to the N-terminal sequences of 
porcine pepsinogen, pseudopepsin and pepsin were 
observed. Therefore it is most likely that the sequen- 
tial activation of pepsinogen, at pH 2, somprises only 
two cleavage steps. If pseudopepsin is cleaved at 
another bond that the one preceding pepsin, the pro- 
duct disappears very fast compared to pseudopepsin. 
Both pseudopepsin and pepsin have isoleucine as 
N-terminal residue. We can therefore quantitate the 
cleavage of pepsinogen by determination of trichloro- 
acetic acid precipitated material with N-terminal isoleu- 
tine. The cleavage rate of pepsinogen is presented in 
fig.2. The pepsinogen gradually disappears, but after 
30 min as well as after 60 min 10% of uncleaved 
pepsinogen was left. The relative amount of cleavage 
was corrected for this apparently unreactive material. 
Within the range of pepsinogen concentrations used 
in the experiments presented in fig.2 the rate of 
cleavage is independent of the concentrations. This 
indicates that with the present conditions of activa- 
tion, the rate limiting step is a first-order reaction, 
representing either a’ conformational change or intra- 
molecular cleavage of the zymogen. 
The formation of N-terminal isoleucine represents 
the sum of preudopepsin and pepsin. The ratio 
between the two proteins was calculated from the 
ratio between lysine and glycine liberated at Step 2 
of the Edman degradation and between glycine and 
glutamic acid liberated at Step 4. The quantitative 
analyses showed a background of lo- 15% of glycine 
and alanine, so the accuracy of the method only allows 
presentation of results as integers of 10 such as shown 
in table 1. These results confirm that the predominant 
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Fig.2. Appearance of milk-clotting activity during activation of pepsinogen 0.08 mg/ml, (0) (solid line). Appearance of N-terminal 
isoleucine by activation of pepsinogen (0) 0.08 mg/ml, (o) 0.13 mg/ml, (A) 0.16 mg/ml. The dashed-line curve shows the course of 
a first-order reaction with the velocity-constant 0.12 min-’ . 
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Table 1 
Activation of porcine pepsinogen A 
Pepsinogen 
concentration 
(mg/mB 
Percent pseudopepsin of cleaved pepsinogen 
Activation time (mm) 
0.8 4 7 10 30 60 
0.08 - _ 70 - 70 60 
0.13 100 80 _ - - - 
0.16 - 80 - 60 40 - 
0.32 - - _ - 30 - 
-Not determined 
Pseudopepsin and pepsin were determined by quantitative sequencing of the first 
four residues. The relative amounts of pseudopepsin are expressed as percent of the 
sum of pseudopepsin and pepsin at any given time. 
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initial cleavage product, at pH 2, is pseudopepsin. They effect has been minimized by the use of citrate to 
further suggest hat the subsequent formation of adjust the pH to 5.3 after activation. Furthermore the 
pepsin is concentration-dependent. In more concen- activity is compared with the maximum activity of an 
trated solutions, pseudopepsin is converted more activation mixture also containing inhibitor peptides. 
rapidly into pepsin, and this may explain why Sanny The low value of the activity at the plateau in fig.2 
et al. [ 1 l] observed only pepsin in their experiments could be explained by a lower activity of pseudopepsin 
with activation of pepsinogen in higher concentrations com.pared with the activity of pepsin or by stronger- 
than we used here. inhibition of pseudopepsin. 
The rate of appearance of milk-clotting activity 
during activation of porcine pepsinogen, 0.08 mg/ml, 
is presented in fig.2. The specific activity reaches a 
plateau which is 73% of the maximum specific activity 
obtained by full activation in a more concentrated 
solution. From table 1 it is seen that there is 70% pseu- 
dopepsin in the mixture when the plateau activity is 
reached. Therefore we can conclude that pseudopepsin 
has milk-clotting activity. We also found that it is 
alkalin-labile; after exposure to pH 8.5 at 25°C for 
20 min less than 5% of the milk clotting activity was 
left. 
Through we cannot account for all quantitative 
aspects of the activation, the results unambiguously 
demonstrate the presence of enzymatically active 
pseudopepsin as an intermediate in the activation of 
porcine pepsimogen at pH 2. Other pathways of 
activation may dominate at higher values of pH, but 
experiments in progress indicate that activation at 
pH 2 of bovine pepsinogen and prochymosin is 
analogous to that of porcine pepsinogen. 
Comparison of the appearance of new N-termrm and 
determination of enzymatic activity through the 
milk-clotting assay is complicated for several reasons: 
we do not know the exact activity of pseudopepsin 
relative to pepsin, and we do not yet know if the 
propart peptide (inhibitor peptide [ 1 ,171) dissociates 
slowly from pseudopepsin or pepsin in our assay. 
However, it is our experience that the inhibition 
appears weaker in citrate than in acetate, therefore the 
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